NASDAQ: PALIPalisade Bio Inc Stock Ownership - Who owns Palisade Bio?
Insider buying vs selling
Have Palisade Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mitchell Lawrence Jones | Pres;Med | 2026-10-06 | 1,031,102 | $1.49 | $1.54MSell |
| John David Finley | CEO;CFO | 2026-10-06 | 1,411,982 | $1.49 | $2.10MSell |
| Donald Allen Williams | Director | 2026-10-02 | 10,000 | $1.46 | $14.60kBuy |
| Donald Allen Williams | Director | 2026-10-01 | 10,000 | $1.42 | $14.20kBuy |
| Robert Baltera Jr. | Director | 2026-07-09 | 25,000 | $1.96 | $48.90kBuy |
| Robert Baltera Jr. | Director | 2026-07-08 | 20,000 | $1.99 | $39.80kBuy |
| John David Finley | CEO CFO | 2026-07-07 | 133 | $0.70 | $93.10Buy |
| Robert Baltera Jr. | Director | 2026-07-07 | 30,000 | $2.04 | $61.05kBuy |
| John David Finley | CEO CFO | 2026-07-07 | 146,798 | $2.07 | $303.28kSell |
| Mitchell Lawrence Jones | Chief Medical Officer | 2026-07-07 | 51,880 | $2.05 | $106.56kSell |
PALI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PALI insiders and whales buy or sell their stock.
PALI Shareholders
What type of owners hold Palisade Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John David Finley | 1.17% | 2,033,192 | $2.30M | Insider |
| Richard Garr | 1.14% | 1,986,304 | $2.24M | Insider |
| Regional Medical Center Yuma | 1.04% | 1,814,375 | $2.05M | Insider |
| Mitchell Lawrence Jones | 0.97% | 1,683,757 | $1.90M | Insider |
| Donald Allen Williams | 0.92% | 1,596,294 | $1.80M | Insider |
| Princeton Capital Corp | 0.74% | 1,293,814 | $1.46M | Insider |
| Stanley Westreich | 0.68% | 1,193,281 | $1.35M | Insider |
| Karl Johe | 0.53% | 930,373 | $1.05M | Insider |
| Julien E. Capers | 0.45% | 787,300 | $889.65k | Insider |
| Binxian Wei | 0.35% | 613,355 | $693.09k | Insider |
PALI vs Biotech Stocks
Palisade Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.